ProVerum Medical

About

ProVerum Medical is a medtech company that develops novel minimally invasive devices to treat benign prostatic hyperplasia.

Dublin,Dublin,Ireland
1 - 10

Highlights

Details

Last Funding Type: Seed
Last Funding Money Raised: €3.50M
Industries: Health Care,Medical Device
Founded date: Jan 1, 2014
Number Of Employee: 1 - 10
Operating Status: Active
Legal Name: ProVerum ltd.

ProVerum Medical is a medtech company that develops novel minimally invasive devices to treat benign prostatic hyperplasia. ProVerum's technology enables patients to receive safe and effective BPH treatment in the doctor's office or operating room in a less invasive, more patient-friendly manner than currently available BPH treatments.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

4

€36.99M

ProVerum Medical has raised a total of €36.99M in funding over 2 rounds. Their latest funding was raised on Jan 11, 2022 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jan 11, 2022	Series A	€30M	3	Gilde Healthcare Lightstone Ventures	—	Detail
May 8, 2018	Seed	€3.50M	6	Atlantic Bridge University Fund	—	Detail
Apr 26, 2017	Seed	—	1	—	—	Detail
May 25, 2016	Seed	€3.49M	6	Atlantic Bridge University Fund	—	Detail

Investors

Number of Lead Investors

Number of Investors

4

9

ProVerum Medical is funded by 9 investors. Gilde Healthcare and Lightstone Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilde Healthcare	Yes	Series A
Lightstone Ventures	Yes	Series A
Atlantic Bridge University Fund	—	Series A
Boole	—	Seed
Xenium Capital	—	Seed
Enterprise Ireland	—	Seed
Halo Business Angel Network	—	Seed
Irrus Investments	—	Seed
MedTech Strategist	—	Seed